Fate Therapeutics, Inc.
USD2.57
-0.17 (-6.20%)
CEO
Bahram Valamehr
IPO Date
2013-10-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.71
Prev. Close
$2.74
Day Low
$2.55
Day High
$2.77
52W Low
$0.91
52W High
$2.88
Market Cap
$0.30B
Volume
2.92M
| 28,946 |
| $1.88 |
| 7 May 2026 | TAHL CINDY | See Remarks | M-Exempt | Acquired | 122,220 | $1.32 |
| 7 May 2026 | TAHL CINDY | See Remarks | M-Exempt | Acquired | 44,444 | $1.05 |
| 7 May 2026 | TAHL CINDY | See Remarks | M-Exempt | Disposed | 122,220 | $1.32 |
| 7 May 2026 | TAHL CINDY | See Remarks | M-Exempt | Disposed | 44,444 | $1.05 |
| 6 May 2026 | EPSTEIN ROBERT S | director | M-Exempt | Acquired | 25,000 | $1.69 |
| 6 May 2026 | EPSTEIN ROBERT S | director | M-Exempt | Acquired | 25,000 | $1.69 |
| 6 May 2026 | RASTETTER WILLIAM H | director | M-Exempt | Acquired | 25,000 | $1.69 |
| 6 May 2026 | RASTETTER WILLIAM H | director | M-Exempt | Acquired | 25,000 | $1.69 |